(Q35056046)

6 August 2017

1 reference

title

Recent developments in the treatment of sepsis (English)

1 reference

6 August 2017

0 references

Vinay K Sharma

1

1 reference

6 August 2017

R Phillip Dellinger

series ordinal

2

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

Expert Opinion on Investigational Drugs

6 August 2017

published in

1 reference

6 August 2017

volume

12

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

139-152

1 reference

Has the mortality of septic shock changed with time

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Antibodies against CD14 protect primates from endotoxin-induced shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

A lipid A analog, E5531, blocks the endotoxin response in human volunteers with experimental endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Effects of continuous haemofiltration vs intermittent haemodialysis on systemic haemodynamics and splanchnic regional perfusion in septic shock patients: a prospective, randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

High-volume haemofiltration in human septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

A pilot study of coupled plasma filtration with adsorption in septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

C1-inhibitor in patients with severe sepsis and septic shock: beneficial effect on renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Protective effects of C5a blockade in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Role of C5a in multiorgan failure during sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: a placebo-controlled, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

A double-blind placebo-controlled study of an infusion of lexipafant (Platelet-activating factor receptor antagonist) in patients with severe sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Sepsis-induced acute lung injury is attenuated by selectin blockade following the onset of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Soluble L-selectin attenuates tumor necrosis factor-alpha-mediated leukocyte adherence and vascular permeability: a protective role for elevated soluble L-selectin in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

HMG-1 as a late mediator of endotoxin lethality in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Filgrastim in patients with pneumonia and severe sepsis or septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

ONO-1714, a new inducible nitric oxide synthase inhibitor, attenuates diaphragmatic dysfunction associated with cerulein-induced pancreatitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

The modulation of hepatic injury and heat shock expression by inhibition of inducible nitric oxide synthase after hemorrhagic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Initial evaluation of diaspirin cross-linked hemoglobin (DCLHb) as a vasopressor in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Neuroprotection by a caspase inhibitor in acute bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Caspase inhibition prevents cardiac dysfunction and heart apoptosis in a rat model of sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Poly (ADP-ribose) synthetase activation mediates pulmonary microvascular and intestinal mucosal dysfunction in endotoxin shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Effects of nicotinamide, an inhibitor of PARS activity, on gut and liver O2 exchange and energy metabolism during hyperdynamic porcine endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Protective effect of a novel, potent inhibitor of poly(adenosine 5'-diphosphate-ribose) synthetase in a porcine model of severe bacterial sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Depletion of neurohypophyseal content of vasopressin in septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Beneficial effects of short-term vasopressin infusion during severe septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Terlipressin for norepinephrine-resistant septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Steroid controversy in sepsis and septic shock: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Dexamethasone in adults with bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Reversal of late septic shock with supraphysiologic doses of hydrocortisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Dysfunction of Endothelial Protein C Activation in Severe Meningococcal Sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.2.139

10.1517/13543784.12.2.139

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference